Market Risers: easyJet, Ilika, ImmuPharma, Intercontinental Hotels Group

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Stock in easyJet with company EPIC: LON:EZJ has stepped up 16.6% or 84.2 points during the course of today’s session so far. Market buyers have remained optimistic while the stock has been in play. The periods high has reached 642.4 dipping to 526. The amount of shares exchanged has so far reached 3,328,675 with the daily average traded share volume around 4,421,549. The 52 week high for the shares is 1570 about 1062.8 points difference from the previous close and the 52 week low at 410 making a difference of 97.2 points. easyJet now has a 20 SMA of 1022.87 and now a 50 day simple moving average now at 1314.9. Market capitalisation is now £2,349.09m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for easyJet being recorded at Friday, March 20, 2020 at 11:55:58 AM GMT with the stock price trading at 591.4 GBX.

The trading price for Ilika ticker lookup code: LON:IKA has increased 15.78% or 4.5 points during today’s session so far. Buyers have stayed positive during the session. The high for the period has reached 33 and hitting a low of 29. Volume total for shares traded at this point reached 64,212 whilst the daily average number of shares exchanged is just 222,765. The stock 52 week high is 52 which comes in at 23.5 points in difference to the previous days close of business and a 52 week low sitting at 19 is a variance of 9.5 points. Ilika now has a 20 moving average of 38.95 and now its 50 day SMA of 42.05. Market capitalisation is now £34.90m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Ilika being recorded at Friday, March 20, 2020 at 10:54:47 AM GMT with the stock price trading at 33 GBX.

Stock in ImmuPharma with company EPIC: LON:IMM has increased 12.5% or 1.05 points during the course of today’s session so far. Market buyers have remained positive during this period. The period high was 9.5 dipping to 7.6. Volume total for shares traded during this period was 335,515 whilst the daily average number of shares exchanged is just 732,778. The 52 week high is 32.2 some 23.8 points different to the previous business close and a 52 week low sitting at 6.91 which is a variance of 1.49 points. ImmuPharma has a 20 day moving average of 12.4 and the 50 day moving average of 14.18. The current market capitalisation is £15.82m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for ImmuPharma being recorded at Friday, March 20, 2020 at 11:53:44 AM GMT with the stock price trading at 9.45 GBX.

Shares of INTERCONTINENTAL HOTELS GROUP Common Stock with company EPIC: LON:IHG has climbed 11.8% or 281.5 points throughout the session so far. Market buyers have stayed positive while the stock has been in play. Range high for the period so far is 2940 and hitting a low of 2467.5. The amount of shares exchanged has so far reached 895,675 whilst the average number of shares exchanged is 1,258,075. A 52 week high for the stock is 5770 about 3384.5 points difference from the previous days close and putting the 52 week low at 2161 is a variance of 224.5 points. INTERCONTINENTAL HOTELS GROUP Common Stock now has a 20 SMA at 4035.58 and now the 50 day MA at 4582.25. Market capitalisation for the company is £4,871.44m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for INTERCONTINENTAL HOTELS GROUP Common Stock being recorded at Friday, March 20, 2020 at 11:55:50 AM GMT with the stock price trading at 2667 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Ilika plc's CEO discusses strategic advancements, partnership with Cirtec, EV sector challenges, and the implications of US election results on their growth.
Ilika plc's CEO discusses a breakthrough in solid-state battery tech for EVs with successful testing of 10Ah cells in the Goliath project.
Ilika plc achieves a major milestone with its Goliath solid-state batteries, successfully testing 10Ah cells and advancing towards a market-ready MVP.
Ilika plc, a leader in solid-state battery tech, is poised for growth with key milestones in medical and automotive sectors targeted for 2025.
Ilika plc updates on its solid-state battery advances, focusing on Stereax for AIMDs and Goliath for EVs, maintaining its full-year guidance.

Search

Search